Pfizer | PFE

Stock Price
28.70
Daily Change
0.43 1.53%
Monthly
5.32%
Yearly
-24.51%
Q2 Forecast
28.56
Peers Price Chg Day Year Date
AbbVie 160.70 4.56 2.92% 20.43% May/31
Abbott 102.25 0.40 0.39% -0.55% May/31
ALKERMES 23.40 0.19 0.82% -20.08% May/31
Amgen 305.48 4.54 1.51% 42.57% May/31
AstraZeneca 12,190.00 162.00 1.35% 4.46% May/31
Bayer 28.24 0.19 0.66% -45.59% May/31
Biogen 224.97 5.08 2.31% -25.61% May/31
Bristol-Myers Squibb 41.14 0.88 2.19% -36.39% May/31
Catalent 53.80 0.15 0.27% 45.41% May/31
Gilead Sciences 64.00 0.13 0.20% -16.02% May/31
GlaxoSmithKline 1,766.50 36.50 2.11% 31.08% May/31
Glaxosmithkline 44.74 0.72 1.64% 32.37% May/31
J&J 146.71 1.47 1.01% -5.07% May/31
Eli Lilly 820.34 7.42 0.91% 87.94% May/31
Medtronic 81.37 0.79 0.98% -1.67% May/31
Merck 125.59 1.02 0.82% 13.22% May/31
Neurocrine Biosciences 135.41 -1.25 -0.91% 48.49% May/31
Novartis 92.96 1.73 1.90% 5.56% May/31
Novartis 103.02 2.26 2.24% 6.09% May/31
Prestige Brands 64.30 1.50 2.39% 13.40% May/31
Pacira 30.33 -0.13 -0.43% -20.27% May/31
Pfizer 28.70 0.43 1.53% -24.51% May/31
Perrigo 27.54 0.04 0.13% -14.10% May/31
Drreddys Laboratories 68.62 -1.24 -1.77% 22.93% May/31
Regeneron Pharmaceuticals 980.16 8.27 0.85% 34.05% May/31
Roche Holding 231.00 2.70 1.18% -20.28% May/31
Sanofi 89.76 1.19 1.34% -4.72% May/31
Sanofi 49.02 1.16 2.42% -2.85% May/31
Vertex Pharmaceuticals 454.94 11.98 2.70% 40.58% May/31
Zoetis 169.75 0.57 0.34% 2.26% May/31

Indexes Price Day Year Date
US500 5278 42.03 0.80% 25.03% May/31

Pfizer traded at $28.70 this Friday May 31st, increasing $0.43 or 1.53 percent since the previous trading session. Looking back, over the last four weeks, Pfizer gained 5.32 percent. Over the last 12 months, its price fell by 24.51 percent. Looking ahead, we forecast Pfizer to be priced at 28.56 by the end of this quarter and at 27.74 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.